-
NTLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Intellia Therapeutics (NTLA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 134.10 mm | 134.10 mm | 134.10 mm | 134.10 mm | 134.10 mm | 134.10 mm |
Cash burn (monthly) | 3.45 mm | 3.91 mm | 48.26 mm | 44.81 mm | 28.28 mm | 29.73 mm |
Cash used (since last report) | 12.44 mm | 14.08 mm | 173.94 mm | 161.51 mm | 101.93 mm | 107.15 mm |
Cash remaining | 121.66 mm | 120.02 mm | -39.84 mm | -27.41 mm | 32.17 mm | 26.95 mm |
Runway (months of cash) | 35.3 | 30.7 | -0.8 | -0.6 | 1.1 | 0.9 |
13F holders | Current |
---|---|
Total holders | 281 |
Opened positions | 41 |
Closed positions | 53 |
Increased positions | 110 |
Reduced positions | 84 |
13F shares | Current |
---|---|
Total value | 1.84 tn |
Total shares | 99.04 mm |
Total puts | 867.80 k |
Total calls | 442.25 k |
Total put/call ratio | 2.0 |
Largest owners | Shares | Value |
---|---|---|
ARK Investment Management | 12.26 mm | $251.85 bn |
BlackRock | 9.77 mm | $200.83 bn |
Vanguard | 9.63 mm | $197.85 bn |
STT State Street | 5.14 mm | $105.70 bn |
Deep Track Capital | 4.95 mm | $101.72 bn |
REGN Regeneron Pharmaceuticals | 3.70 mm | $437.84 mm |
CMTDF Sumitomo Mitsui Trust | 3.15 mm | $64.72 bn |
Nikko Asset Management Americas | 3.15 mm | $64.67 bn |
FHI Federated Hermes | 2.74 mm | $56.32 bn |
MS Morgan Stanley | 2.58 mm | $52.94 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 25 | Laura Sepp-Lorenzino | Common Stock | Sell | Dispose S | No | No | 12.18 | 8,966 | 109.21 k | 77,388 |
3 Jan 25 | David Lebwohl | Common Stock | Sell | Dispose S | No | No | 12.18 | 9,557 | 116.40 k | 87,666 |
3 Jan 25 | Derek Hicks | Common Stock | Sell | Dispose S | No | No | 12.18 | 6,502 | 79.19 k | 59,878 |
3 Jan 25 | Basta James | Common Stock | Sell | Dispose S | No | No | 12.18 | 7,074 | 86.16 k | 74,497 |
3 Jan 25 | Michael P Dube | Common Stock | Sell | Dispose S | No | No | 12.18 | 1,372 | 16.71 k | 45,640 |